Literature DB >> 33710927

Global REACH 2018: dysfunctional extracellular microvesicles in Andean highlander males with excessive erythrocytosis.

L Madden Brewster1, Anthony R Bain2, Vinicius P Garcia1, Hannah K Fandl1, Rachel Stone2, Noah M DeSouza1,3, Jared J Greiner1, Michael M Tymko4, Gustavo A Vizcardo-Galindo5, Romulo J Figueroa-Mujica5, Francisco C Villafuerte5, Philip N Ainslie3, Christopher A DeSouza1.   

Abstract

High altitude-related excessive erythrocytosis (EE) is associated with increased cardiovascular risk. The experimental aim of this study was to determine the effects of microvesicles isolated from Andean highlanders with EE on endothelial cell inflammation, oxidative stress, apoptosis, and nitric oxide (NO) production. Twenty-six male residents of Cerro de Pasco, Peru (4,340 m), were studied: 12 highlanders without EE (age: 40 ± 4 yr; BMI: 26.4 ± 1.7; Hb: 17.4 ± 0.5 g/dL, Spo2: 86.9 ± 1.0%) and 14 highlanders with EE (43 ± 4 yr; 26.2 ± 0.9; 24.4 ± 0.4 g/dL; 79.7 ± 1.6%). Microvesicles were isolated, enumerated, and collected from plasma by flow cytometry. Human umbilical vein endothelial cells were cultured and treated with microvesicles from highlanders without and with EE. Microvesicles from highlanders with EE induced significantly higher release of interleukin (IL)-6 (89.8 ± 2.7 vs. 77.1 ± 1.9 pg/mL) and IL-8 (62.0 ± 2.7 vs. 53.3 ± 2.2 pg/mL) compared with microvesicles from healthy highlanders. Although intracellular expression of total NF-κB p65 (65.3 ± 6.0 vs. 74.9 ± 7.8.9 AU) was not significantly affected in cells treated with microvesicles from highlanders without versus with EE, microvesicles from highlanders with EE resulted in an ∼25% higher (P < 0.05) expression of p-NF-κB p65 (173.6 ± 14.3 vs. 132.8 ± 12.2 AU). Cell reactive oxygen species production was significantly higher (76.4.7 ± 5.4 vs. 56.7 ± 1.7% of control) and endothelial nitric oxide synthase (p-eNOS) activation (231.3 ± 15.5 vs. 286.6 ± 23.0 AU) and NO production (8.3 ± 0.6 vs. 10.7 ± 0.7 μM/L) were significantly lower in cells treated with microvesicles from highlanders with versus without EE. Cell apoptotic susceptibility was not significantly affected by EE-related microvesicles. Circulating microvesicles from Andean highlanders with EE increased endothelial cell inflammation and oxidative stress and reduced NO production.NEW & NOTEWORTHY In this study, we determined the effects of microvesicles isolated from Andean highlanders with excessive erythrocytosis (EE) on endothelial cell inflammation, oxidative stress, apoptosis, and NO production. Microvesicles from highlanders with EE induced a dysfunctional response from endothelial cells characterized by increased cytokine release and expression of active nuclear factor-κB and reduced nitric oxide production. Andean highlanders with EE exhibit dysfunctional circulating extracellular microvesicles that induce a proinflammatory, proatherogenic endothelial phenotype.

Entities:  

Keywords:  endothelial cells; erythrocytosis; highlanders; microvesicles

Mesh:

Substances:

Year:  2021        PMID: 33710927      PMCID: PMC8163655          DOI: 10.1152/ajpheart.00016.2021

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  77 in total

Review 1.  MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease.

Authors:  Maarten Hulsmans; Paul Holvoet
Journal:  Cardiovasc Res       Date:  2013-06-16       Impact factor: 10.787

2.  A modeled dynamic regulatory network of NF-κB and IL-6 mediated by miRNA.

Authors:  Xu Xue; Wang Xia; Hu Wenzhong
Journal:  Biosystems       Date:  2013-09-10       Impact factor: 1.973

Review 3.  Extracellular vesicles as new pharmacological targets to treat atherosclerosis.

Authors:  Min Yin; Xavier Loyer; Chantal M Boulanger
Journal:  Eur J Pharmacol       Date:  2015-07-02       Impact factor: 4.432

Review 4.  The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation.

Authors:  Allan R Brasier
Journal:  Cardiovasc Res       Date:  2010-03-03       Impact factor: 10.787

5.  Effects of HIV-1 gp120 and TAT-derived microvesicles on endothelial cell function.

Authors:  Jamie G Hijmans; Kelly Stockelman; Ma'ayan Levy; L Madden Brewster; Tyler D Bammert; Jared J Greiner; Elizabeth Connick; Christopher A DeSouza
Journal:  J Appl Physiol (1985)       Date:  2019-02-21

6.  Thrombosis triggered by severe arterial lesions is inhibited by oral administration of a glycoprotein IIb/IIIa antagonist.

Authors:  J J Badimon; B Meyer; L P Feigen; D A Baron; J H Chesebro; V Fuster; L Badimon
Journal:  Eur J Clin Invest       Date:  1997-07       Impact factor: 4.686

7.  Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK.

Authors:  Rudolf Waelchli; Birgit Bollbuck; Christian Bruns; Thomas Buhl; Jörg Eder; Roland Feifel; Rene Hersperger; Philipp Janser; Laszlo Revesz; Hans-Günter Zerwes; Achim Schlapbach
Journal:  Bioorg Med Chem Lett       Date:  2005-10-19       Impact factor: 2.823

8.  Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells.

Authors:  Anat Aharon; Tal Tamari; Benjamin Brenner
Journal:  Thromb Haemost       Date:  2008-11       Impact factor: 5.249

9.  Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice.

Authors:  Thomas Quaschning; Frank Ruschitzka; Thomas Stallmach; Sidney Shaw; Henning Morawietz; Winfried Goettsch; Matthias Hermann; Torsten Slowinski; Franz Theuring; Berthold Hocher; Thomas F Lüscher; Max Gassmann
Journal:  FASEB J       Date:  2002-12-18       Impact factor: 5.191

10.  The 2018 Global Research Expedition on Altitude Related Chronic Health (Global REACH) to Cerro de Pasco, Peru: an Experimental Overview.

Authors:  Michael M Tymko; Ryan L Hoiland; Joshua C Tremblay; Mike Stembridge; Tony G Dawkins; Geoff B Coombs; Alexander Patrician; Connor A Howe; Travis D Gibbons; Jonathan P Moore; Lydia L Simpson; Craig D Steinback; Victoria L Meah; Benjamin S Stacey; Damian M Bailey; David B MacLeod; Christopher Gasho; James D Anholm; Anthony R Bain; Justin S Lawley; Francisco C Villafuerte; Gustavo Vizcardo-Galindo; Philip N Ainslie
Journal:  Exp Physiol       Date:  2020-05-06       Impact factor: 2.969

View more
  1 in total

Review 1.  Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis.

Authors:  Rosa Suades; Maria Francesca Greco; Teresa Padró; Lina Badimon
Journal:  Cells       Date:  2022-06-05       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.